Publicacions en què col·labora amb Celia Prior Darbonnens (3)

2012

  1. Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts

    Laboratory Investigation, Vol. 92, Núm. 7, pp. 952-966

  2. The quinoline imidoselenocarbamate EI201 blocks the AKT/mTOR pathway and targets cancer stem cells leading to a strong antitumor activity

    Current Medicinal Chemistry, Vol. 19, Núm. 18, pp. 3031-3043

2011

  1. Therapeutic effect of lenalidomide in a novel xenograft mouse model of human blastic NK cell lymphoma/blastic plasmacytoid dendritic cell neoplasm

    Clinical Cancer Research, Vol. 17, Núm. 19, pp. 6163-6173